News
MarketBeat on MSN1mon
IGV: Play the Next Phase of the AI Movement With This ETFMany see this as the next phase of AI. This brings up an interesting fund, the iShares Expanded Tech-Software Sector ETF ...
Hosted on MSN2mon
Imvax Secures $29 Million to Advance Glioblastoma Therapy TrialIf successful, IGV-001 could represent a groundbreaking step forward in glioblastoma therapy and improve outcomes for thousands of patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback